FDA Inspection 1154229 — Jian Fang
The FDA completed an inspection of Jian Fang on September 22, 2021 in Beijing. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- September 22, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Beijing (China)
Additional Details
Clinical Investigator (CI)